Top 10 Medical Startup Investors in Iceland (May 2026)

The New Business Venture Fund is an evergreen investment fund that actively contributes to the development and growth of the Icelandic economy by investing in promising innovation and start-up companies.The New Business Venture Fund invests at seed and early stage in promising growth companies with great business ideas and strong management anddevelopment teams.The New Business Venture Fund is a state owned investment fund intended to strengthen and develop the Icelandic venture capital market along with promoting startups and business in Iceland thus encouraging economic growth.

Investment focus

Industry: Software, Health Care, Medical
Stage:Seed, Series A
Geography: Iceland, United States, China

Investor stats

Total investments: 37
Round size: Seed $400k–$2.6M; Series A $450k–$3.4M
Lead/follow: 62% lead, 38% follow

Portfolio highlights

HorseDay — HorseDay is a mobile application to track horse activities.
Spectaflow — Simple housekeeping and task management for hospitality. More effective operations without printouts, phone calls, and yellow stickers. Learn more!
PayAnalytics — PayAnalytics helps companies monitor, address and close pay gaps. Comply with regulations, use built-in reports or customize your own. Pay equity decisions made easy for HR and compensation managers as well as consultants. Used in over 75 countries for organizations of all sizes.

Show all investments...

Novator is an alternative investment firm founded and led by the international investor and entrepreneur Thor Bjorgolfsson.Novator's investment portfolio is focused around following sectors: Telecommunications, Pharmaceuticals, IT and Renewable Energy. In addition, Novator operates a Private Equity Fund and a Credit Opportunities Fund.Novator focuses on developing strong management teams in each of its portfolio companies. While granting them the autonomy to create value, Novator maintains a supervisory role, principally through representation on the Boards of its investee companies. Novator differentiates itself from many other private equity companies in concentrating on complex situations, either by virtue of their structure or their cross-border nature. To create value, Novator undertakes the restructuring or "de-risking" of investment opportunities through re-financing, combining acquired assets with existing businesses, through sale to strategic or financial buyers, or through flotation. Novator's investment portfolio is focused around four main sectors:Telecommunications, Pharmaceuticals, IT and Renewable Energy.

Investment focus

Industry: Information Technology, Software, E-Commerce
Stage:Series A, Series B
Geography: United Kingdom, Iceland, Germany

Investor stats

Total investments: 43
Round size: Series A $12M–$25M; Series B $16M–$40M
Lead/follow: 42% lead, 58% follow

Portfolio highlights

Olive — Olive's technology evaluation platform finds & compares your best-match enterprise software & manages the selection process. Build requirements from pre-built libraries. Compare all solutions in the market against your unique business needs. Olive takes the best practices of digital transformation and shortens the process allowing you to make smart decisions, faster.
Klang Games — Klang Games is an entertainment & game development studio in Berlin, developing the MMO Simulation and Virtual World, Seed. Klang is always hiring!
Sidekick Health — Our mission is to develop and deliver effective personalized digital therapeutics that prevent suffering and add millions of quality life years to people around the world. Our multi-chronic digital care platform allows us to scale the production of clinical treatments across major chronic diseases.

Show all investments...

Silicon Valley Bank works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven internationaloperations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.

Investment focus

Industry: Software, Health Care, Biotechnology
Stage:Debt Financing, Series B, Series A
Geography: United States, United Kingdom, Canada

Investor stats

Total investments: 368
Round size: Series A $4M–$30M; Series B $5.5M–$42M; Debt Financing $5M–$145M
Lead/follow: 28% lead, 72% follow
Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

8fig — Get funded now and scale your eCommerce store smarter and faster. 8fig's financing solutions will provide the resources you need.
6sense — Achieve predictable revenue growth with the 6sense Account Engagement Platform.
Achieve — Achieve provides digital personal finance solutions to help everyday people get on the path to a better financial future, with innovative technology and personalized support. By leveraging proprietary data and analytics, the solutions are designed for a consumer's financial journey and include personal loans, home loans, help with debt, andfinancial tools and education. Achieve is headquartered in San Mateo, California.

Show all investments...

Frumtak (a.k.a. Frumtak Investment Fund, Frumtak I, Frumtak 1) was founded December 23rd. 2008. The objective was to invest in early stage growth companies that were post seed and had growth potential. This would result in leading companies that could deliver a good return to investors.At the close of Frumtak‘s investment period on December 31st.2012, the fund had invested in fifteen companies with nine investments still active. The remainder of lifetime of the fund is used to follow on investments and divest assets.Frumtak Ventures (Frumtak II, Frumtak 2) started in February 2015. The fund builds on the legacy of Frumtak 1. The fund invests in early stage innovative companies that are post seed and show great potential for growth. The fund invests primarily in Iceland but is allowed to invest abroad as allowed by law in connection with its portfolio investments to ensure success in foreign markets.Frumtak II emphasizes to invest in companies where growth and sales in foreign markets are the primary objective, but does not specialize in any particular industry. The fund wants to ensure that original ideas get a chance and thereby increasing the probability of creating growth and value. By doing this, it enforces the image that Icelandic innovation is profitable.Frumtak II aspires to be a trusted and popular ally. The fund strives to have a good relationship and co-operation with all stakeholders within the start-up and innovation community. The fund puts a special emphasis on co-operating with stakeholders outside Iceland.

Investment focus

Industry: Software, Information Technology, Enterprise Software
Stage:Seed, Series A
Geography: Iceland, United States, United Kingdom

Investor stats

Total investments: 29
Round size: Seed $380k–$2.7M; Series A $1.2M–$6.5M
Lead/follow: 69% lead, 31% follow
Last fund: Likely still investing — raised $57M in 2021

Portfolio highlights

50skills — Bring people, information and tools together. 50skills is a hiring system and so much more.
Spectaflow — Simple housekeeping and task management for hospitality. More effective operations without printouts, phone calls, and yellow stickers. Learn more!
Abler — Abler brings simplicity to the complexities of team management. With easy scheduling, messaging, payment, and data tools, Abler empowers users to spend more time cultivating the essential life skills and values learned through sports and other organised activities.

Show all investments...

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Investment focus

Industry: Biotechnology, Health Care, Medical Device
Stage:Series A, Seed, Series B
Geography: Spain, Belgium, Germany

Investor stats

Total investments: 21
Round size: Seed $1.2M–$13M; Series A $4.4M–$32M; Series B $18M–$41M
Lead/follow: 55% lead, 45% follow
Last fund: Likely still investing — raised $107M in 2022

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
Nuage Therapeutics — Nuage Therapeutics is a pharmaceutical company which utilizes chemical biology and biomolecular condensation to develop selective drugs that target proteins with disordered regions for challenging indications to improve patient’s life. The focus of the medication is to enhance selective inhibitors of intrinsically disordered proteins involved inchallenging indications in order to meet unmet medical needs.

Show all investments...

Brunnur Ventures invests in entities in Iceland and has the ability to invest abroad as a part of the expansion of its portfolio companies internationally. The venture firm does not have a specific industry focus. However, it investments in companies that show great growth potential in specific industry sectors. Brunnur Ventures is the GeneralPartner of Brunnur Venture Capital Fund a USD 40M fund.

Investment focus

Industry: Software, SaaS, Biotechnology
Stage:Seed, Series A, Angel
Geography: Iceland, United States, Denmark

Investor stats

Total investments: 24
Round size: Seed $1M–$3.5M; Series A $1.5M–$5.5M
Lead/follow: 67% lead, 33% follow
Last fund: May invest from a new fund soon — raised $65M in 2021

Portfolio highlights

PaxFlow — We empower tour operators to streamline operations PaxFlow helps streamline tour operations with resource management, data based workflows, customer communication and self service tools. Discover Streamlined Tour Management PaxFlow integrates with leading booking system providers and integrates booking data with operational features like resource management, shift scheduling, departure management and customer self service portal to...
Vitar Games — A WW1 Strategy driven Management Game
Standby Deposits — Standby Deposits is a rental security deposit replacement based on credit.

Show all investments...

Sigþór Sigmarsson is Finance director at Novato. He attended Háskóli Íslands.

Investment focus

Industry: Health Care, Medical, Software
Stage:Seed
Geography: Iceland

Investor stats

Total investments: 3
Round size: Seed $400k–$1.6M
Lead/follow: 33% lead, 67% follow

Portfolio highlights

Genis — GENIS is a biotechnology company headquartered in Siglufjörður, Iceland. They strive to discover, develop and commercialize novel and life-changing products, supplements and medical devices derived from crustacean exoskeletons. The GENIS team has been developing cutting-edge research on the production of chitin, chitosan, and short chain chitosanfor two decades. Their mission is to leverage this accumulated body of world-class scientific research with the intent of providing life-altering benefits for individuals.
Treble — We develop next generation sound simulation and spatial audio technology for digital twins and virtual worlds.
3Z Pharmaceuticals — 3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays.Karl Karlsson and Haraldur Thorsteinsson founded 3ZPharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006.

Show all investments...

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.

Investment focus

Industry: Biotechnology, Health Care, Medical
Stage:Series A, Series B
Geography: Sweden, Israel, Iceland

Investor stats

Total investments: 13
Round size: Series A $2.5M–$21M; Series B $12M–$75M
Lead/follow: 38% lead, 62% follow

Portfolio highlights

AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.

Show all investments...

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

Investment focus

Industry: Health Care, Biotechnology, Medical
Stage:Series A, Series B
Geography: Germany, United States, United Kingdom

Investor stats

Total investments: 172
Round size: Series A $3M–$28M; Series B $6.7M–$43M
Lead/follow: 28% lead, 72% follow
Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

Nosto — Use Powerful Personalization Made Easy on e-Commerce Platforms. Nosto generates a 10-30% Average Increase in Revenue.
Minervax — MinervaX is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein : click to read more
Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.

Show all investments...